Hocon Biotechnology Co., Ltd : , , , , , , /: Hubei, China : OEM- : : Hokonbio , ,
Additional risk factors include: Chronic kidney disease : Reduced renal clearance may impair B12 excretion Liver disease : Hepatic dysfunction can disrupt B12 metabolism and storage Myeloproliferative disorders : Certain blood cancers increase B12-binding proteins Concurrent medication use : Some drugs may interact with B12 metabolism, including metformin, proton pump inhibitors, and H2 antagonists Patients with these conditions should have B12 supplementation carefully monitored by their healthcare team
Metin, S
Potential benefits of this infusion include enhanced cellular support, promotion of healthy aging, and a radiant, revitalized look